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SELF-LIMITED TOXOPLASMA PARASITEMIA AFTER LIVER TRANSPLANTATION' 
Although toxoplasmosis is often a mild or asymptomatic 
infection in normal subjects, it may cause lethal disease in 
immunocompromised patients (1-3) . Detection of the disease 
is difficult and often requires histological evidence. Many cases 
are diagnosed at autopsy. We recently isolated Toxoplasma 
gondii in tissue culture from the blood of a febrile liver trans-
plant patient who later developed lymphocytic meningitis. The 
patient recovered completely, despite receiving only short 
courses of antimicrobials active against Toxoplasma. Our ex-
perience illustrates that isolation of Toxoplasma from the blood 
of a solid organ transplant patient may occur with limited 
disease. 
A 57-year-old woman with a two-year history of chronic 
active hepatitis underwent orthotopic liver transplantation and 
received cyclosporine (CsA) and prednisone immunosuppres-
sion. Ampicillin and cefotaxime (4 g each) were given daily for 
five days as antibiotic prophylaxis. At 18 days after the opera-
tion, a liver biopsy showed acute rejection and a 10-day intra-
venous course of mouse OKT3 antibody was administered. At 
24 days after the operation, the patient had a temperature 
elevation to 39.5·C. A computerized tomographic scan of the 
abdomen showed a hypodense 3.5x4.5-cm area in the liver. 
Percutaneous aspiration of this yielded heavy Streptococcus 
[ecalis on culture. Pipercillin, gentamicin, and cefox~itin were 
administered, but then switched to ampicillin, gentamicin, and 
c1indamycin. A drain was left in the liver abscess cavity. Clin-
damycin was discontinued after three days, but ampicillin was 
continued 8 days and gentamicin was continued for 10 days. 
The patient continued to have significant fever while receiving 
these antibiotics. By 39 days after the operation the patient 
was afebrile, but she then developed confusion. A computerized 
tomographic scan of the head was normal, but examination of 
the cerebrospinal fluid showed 360 red blood cells and 50 white 
blood cells (1 neutrophil, 1 mononuclear, and 48 lymphs); the 
glucose was 46 mg% and the protein 48 mg% . Cultures of the 
spinal fluid were sterile. Her peripheral blood smear showed a 
white count of 12,700 with 8% atypical lymphocytes, 22% 
lymphocytes, 63% polymorphonuclear cells, 5% monocytes and 
2% eosinophils. At this time a single dose of i.v. sulfamethox-
azole/trimethoprim (1 g/200 mg) was administered when a 
weakly positive Pneumocysti.s carinii serum antigen (1:2) was 
reported (Linda L. Pifer, Memphis, TN, personal communica-
tion) . This was discontinued because the patient's illness was 
not compatible with Pneumocystis infection. Thereafter, the 
patient improved clinically and was discharged from the hos-
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pitaf 48 days after the operation with no fever or neurological 
problems. Before discharge a buffy coat culture of the blood 
taken 26 days after the operation and inoculated in tubes of 
human foreskin fibroblasts showed cytopathic effect, with swol-
len cells containing multiple inclusions: A wet preparation of 
the culture supernatant showed 2x6-/L oval bodies that were 
motile. These were later identified by electron microscopy as T 
gondii (Fig. 1). 
The same buffy coat was positive for cytomegalovirus, which 
was also isolated from buffy coats obtained on days 34 and 39 
after transplantation. Pretransplant serum showed a titer of 
Epstein-Barr viral capsid antigen of 1:80, and Epstein-Barr 
early antigen of <1:5. Serum from day 39 after transplantation 
showed a 16-fold titer rise of IgG antibody to viral capsid 
antigen, and an 8-fold titer rise of IgG antibody to early antigen. 
Thus the patient showed a significant rise in titer of Epstein-
Barr virus antibodies suggesting reactivation infection. 
Stored donor and pre- and posttransplant recipient sera were 
tested for anti-Toxoplasma IgG antibody by Fiax (M .A. Bio-
products, Walkersville, MD). This is a semiautomated solid-
phase fluorescent antibody test wherein the toxoplasma antigen 
FIGURE 1. Electron microscopy of Toxop/(lsma gondii organisms 
isolated in tissue culture and seen within an intracellular vacuole. The 
arrow point~ to the characteristic conoid at the anterior end of the 
organisms, from which densely staining rophtries arise. 
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is impregnated onto paper strips that are reacted with the 
patient's serum and then with a fluorescein-labeled antihuman 
IgG. The results of these tests and the serial clinical events are 
shown in Figure 2. The recipient showed a seven-fold rise in 
titer by 47 days after transplant. The two seven-day courses of 
low-dose (500 mg/day) oral sulfisoxazole were administered as 
infection prophylaxis but discontinued once a defined infection 
(the liver abscess) was discovered. 
Shepp recently described the isolation in tissue culture of 
Toxoplasma from the blood of three bone marrow transplant 
recipients, all of whom died. Invasive disease was shown in the 
two patients who had a full autopsy (4). This is the first report 
of isolation of Toxoplasma in tissue culture from a solid organ 
transplant recipient and is remarkable for the relatively benign 
course of the infection. Although the patient received antimi-
crobials that may have been active against Toxoplasma, these 
were given in very low doses (sulfisoxazole) or for very short 
courses (clindamycin and sulfamethoxazole/trimethoprim). It 
is possible, of course, that the low doses of sulfisoxazole modi-
fied the illness without actually preventing it. In addition to 
Toxoplasma infection the patient also had cultural evidence of 
cytomegalovirus infection, serological evidence of Epstein-Barr 
virus infection, and a bacterial liver abscess. However, her fever 
persisted for 10 days after drainage of the liver abscess and 
during administration of antibiotics active against the bacterial 
isolates from the abscess, and only disappeared after the anti-
biotics were stopped. 
The lymphocytic meningitis could be explained by Toxo-
plasma infection, but aBso by cytomegalovirus and Epstein-Barr 
virus infections. Both viruses can rarely cause meningoenceph-
alitis with lymphocytic pleocytosis in the cerebral spinal fluid 
(5,6). 
The source of the Toxoplasma infection was unknown, and 
it might have arisen by reactivation of latent infection or been 
transmitted by blood products (7, 8). Transmission by the 
donor organ is also a possibility, but this has not been demon-
stra ted in a liver transplant recipient. 
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FIG URE 2. Clinical and laboratory events after transplantation. On 
the horizontal axis (a) are shown the key clinical events in days 
posttransplantation. Above the horizontal are a longitudinal tempera-
ture curve and the timing of all antibiotics administered in the post-
operative period. The horizontal (b) shows Toxoplasma IgG antibody 
titers (FlAX) of donor and recipient sera collected before and after 
transplantation. A positive titer is greater than 24. The Toxoplasma 
organisms were isolated from a buffy coat culture taken on day 26 but 
were not actually detected until 46 days after transplantation, when 
the patient was well. 
-The significant Toxoplasrnu 'antibody rise suggests that the 
isolate represented more than transient toxoplasmemia. Rem-
ington has stressed that toxoplasma infection is more likely to 
be severe when a seronegative patient undergoes primary infec-
tion after transplantation, and some centers recommend anti-
microbial prophylaxis in such patients (9, 10). This patient's 
established immunity before transplantation may have been an 
important factor in her rapid and complete recovery. 
Although tissue culture of blood is probably not a sensitive 
technique for diagnosing toxoplasmosis, its sensitivity might 
be improved by culturing larger quantities of blood. Awareness 
that Toxoplasma may be isolated in routine viral cultures may 
occasionally aid in the detection of the disease. 
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